Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...

Anbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public offering. Read more here.

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

Prime Minister Narendra Modi on Sunday inaugurated a 13-km section of the Delhi-Meerut Regional Rapid Transit System (RRTS) ...

Jammu:�Police have arrested a government employee for allegedly opening fire at a BJP youth leader following an altercation ...

As 2025 begins, the U.S. IPO market is starting slowly. Nevertheless, the market is rife with news of popular names ...

A team at the University of Calgary is making scientific advances in understanding plant adaptation, which could ultimately be used to find ways to make agricultural crops more resilient to heat ...

Today has seen a lot of movement in Russia's Kursk region, where Ukraine launched an offensive last year. We'll be back tomorrow with more updates on the war in Ukraine. But here is a look at the ...

Israel’s genocide in Gaza has put at least 114 hospitals and clinics out of service, yet nurses and doctors vow to continue providing care under the worst conditions imaginable. Fury at the ...

Dec. 18, 2024 — Researchers studied oxygen treatment as a potential therapy to target specific cells linked to the development of cardiovascular and metabolic disorders like high blood pressure ...